Debra Bingham is the Founder of Valeo Partners, headquartered in Boston, Massachusetts, a leading consultancy providing advisory services to large and emerging Pharma clients in North America, Europe, Asia, the Middle East, and Latin America.
Debra has more than 20 years of experience working with clients in the drug delivery and pharmaceutical industries. Her clients include multinational pharmaceutical, biotech, medical device, and chemical companies as well as medium to small specialty pharma and drug delivery companies. As a result of this deep area expertise, Debra is often asked to consult in the area of drug delivery. Debra is on the Board of Directors for the Controlled Release Society, a member of the Editorial Advisory Board for the Drug Delivery Technology Magazine, a past member of the Advisory Board for the Drug Delivery Partnerships Annual Meetings, is an invited speaker at many industry conferences, and has written numerous articles and white papers on pharmaceutical markets and technologies.
Expertise include business development, licensing, market research, business strategy. Drug delivery markets and technology are an area of deep expertise within Valeo Partners